Safety assessment
meanwhile non-fasting blood glucose
EVENTS, DIABETES MELLITUS
Safety assessments are carried out by evaluating local and systemic reactions experienced by post-vaccination subjects. Subjects were monitored for 30 min post-vaccination to assess the immediate effects of the vaccine. On the 7th and 28th days after vaccination, we conducted a safety laboratory examination consisting of haematology, blood urea nitrogen (BUN), creatinine, sodium, potassium, chloride, phosphorus, calcium, lipid profile, SGOT, SGPT, total protein, albumin, globulin, alkaline phosphatase, total bilirubin, direct bilirubin and lipase. Fasting blood glucose were examined in subjects with diabetes mellitus, meanwhile non-fasting blood glucose were examined in non-diabetic subjects. Patients are continuously monitored to assess unwanted events that occurred in the 3rd, 6th, 9th, and 12th months after vaccination.